|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety comparison of liraglutide,glimepiride,and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | | Diabetes Care0，，： | 2 |
| 2 | Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study显示文摘 | Vessby B Uusitupa M Hermansen K | 2001 | Diabetologia2001，44，3： | 1 |
| 3 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in pa- tients with type 2 diabetes mellitus inadequately con- trolled glimepiride alone or on glimepiride and mefformin 显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 4 | Diet, muscle glycogen and physical performance 显示文摘 | BERGSTR M J HERMANSEN L HULTMAN E | 1967 | Acta Physiol Stand1967，71，2： | 1 |
| 5 | The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cy- tology in the detection of bladder carcinoma 显示文摘 | Badalament RA Hermansen DK Kimmel M | 1987 | Cancer1987，60，7： | 1 |
| 6 | Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD(liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
| 7 | A 26-week,randomized,parallel,treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucoselowering dmgs in insulin-naive people with type 2 diabetes显示文摘 | HERMANSEN K DAVIES M DEREZINSKI T | 2006 | Diabetes Care2006，29，6： | 1 |
| 8 | Preliminary estimates of contemporary soil organic carbon stocks in Denmark using multiple datasets and four scaling-up methods显示文摘 | Krogh L Noergaard A Hermansen M | 2003 | Agriculture Ecosystems and Environment2003，96，： | 1 |
| 9 | Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with mefformin in type 2 diabetes: 2-year results from the LEAD-2 study显示文摘 | Nauck M Frid A Hermansen K | 2013 | Diabetes Obes Metab2013，150，： | 1 |
| 10 | Can the glycemic index(GI) be used as a tool in the prevention and management of type 2 diabetes 显示文摘 | Hermansen M F Eriksen N M Mortensen L S | 2006 | Rev Diabet Stud2006，3，2： | 1 |
| 11 | Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study显示文摘 | Vessby B Unsitupa M Hermansen K | 2001 | Diabetologia2001，44，： | 1 |
| 12 | Efficacy and safety comparison of liraglutide,glimepiride, and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (Liraglutide Effect and Action in Diabetes )-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | J Diabetes Care2009，32，1： | 1 |
| 13 | A prospective analysis of pain experience,beliefs and attitudes,and pain management of a cohort of Danish surgical patients显示文摘 | Lorentzen V Hermansen IL Botti M | 2012 | Eur J Pain2012，16，2： | 1 |
| 14 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or in combination with metformin显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 15 | Efficacy and safety comparison ofliraglutide, glimepiride, and placebo, all in combination with metformin, intype 2 diabetes: the LEAD -2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，： | 1 |
| 16 | A 26-Week, Randomized, Parallel, Treatto-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Na?'' ve People With Type 2 Diabetes 显示文摘 | Hermansen K Clauson P Davies M | 2006 | Diabetes Care2006，29，： | 1 |
| 17 | Efficacy and Safety Comparison of Liraglutide,Glimepiride,and Placebo, All in Combination With Metformin,in type 2 Diabetes显示文摘 | Nauck M Frid A Hermansen K eta/ | 2009 | Diabetes Care2009，32，1： | 1 |
| 18 | Efficacy and safety comparison of llraglutlde, gllmeplrlde, and placebo, all in combination with met- formin, in type 2 diabetes: The LEAD ( liraglutlde effect and action in- diabetes) -2 study 显示文摘 | Nauck M Frid A Hermansen K et aI | 2009 | Diabetes Care2009，32，1： | 1 |
| 19 | Efficacy and safety com- parison of liraglutide, glimepiride, and placebo, all in combina- tion with mefformin, in type 2 diabetes: the LEAD ( liraglutide effect and action in diabetes)-2 study显示文摘 | Nauek M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
| 20 | Effieaey and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in pa-tients with type 2 diabetes mellitus inadequately con- trolled on glimepiride alone or on glimepiride and met- formin显示文摘 | Hermansen K Kipnes M Luo E et d | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员